|
Abstract Objective: To observe the clinical efficacy of drug enema in different positions for treating patients with sequelae of pelvic inflammatory disease. Methods: 120 patients with sequelae of pelvic inflammatory disease who had been treated in Chongqing red cross hospital from June 2016 to August 2017 were selected and divided into control group (n=60) and study group (n=60) according to the random number table method. The patients in control group were given drug retention enema based on traditional left lateral position, while patients in study group were given drug retention enema in prostration position. The drug retention time in the intestinal tract, the score of sense integral after the enema, the changes of symptoms and signs, the improvement of the pelvic masses and the fluid accumulation, and white blood cell count (WBC), the percentage of neutrophils (NEU%) and the percentage of lymphocyte (LYM%) were compared between the two groups. And the clinical efficacy of patients in the two groups was evaluated. Results: The retention time in the intestinal tract and the total effective rate of patients in study group were (836.7±158.4) min and 96.7% (58/60), which were significant better than those of patients in control group ［(561.8±103.7) min and 81.7% (49/60), respectively］. Compared with that before treatment, the symptoms and signs of all patients both in the two groups had alleviated significantly, and alleviated degrees of symptoms and signs of patients in study group were greater than those of patients in control group. The improvement of pelvic effusion, the pelvic masses, and the score of sense integral after the enema of patients in study group were better than those of patients in control group (P<0.05).Compared with those before treatment, there were no significant changes in WBC, NEU% and LYM% after treatment in both groups (P>0.05). Conclusion: The treatment of the sequelae of pelvic inflammatory disease by drug enema in the prone position can obviously improve the clinical effect, prolong the drug retention time in the intestinal tract, and can relieve the clinical symptoms, and has high safety. So it is worth clinical application.
|
|
|
|
|
|
